Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$5.21 - $12.14 $1.34 Million - $3.12 Million
-256,756 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$7.34 - $17.16 $22,240 - $51,994
3,030 Added 1.19%
256,756 $2.61 Million
Q4 2021

Feb 14, 2022

BUY
$11.38 - $53.41 $2.05 Million - $9.61 Million
179,992 Added 244.11%
253,726 $4.23 Million
Q3 2021

Nov 15, 2021

BUY
$46.87 - $64.24 $1.29 Million - $1.76 Million
27,425 Added 59.22%
73,734 $3.46 Million
Q2 2021

Aug 16, 2021

BUY
$46.47 - $63.93 $49,304 - $67,829
1,061 Added 2.34%
46,309 $2.82 Million
Q1 2021

May 17, 2021

SELL
$55.47 - $72.35 $1.96 Million - $2.56 Million
-35,422 Reduced 43.91%
45,248 $2.79 Million
Q4 2020

Feb 16, 2021

SELL
$38.38 - $71.11 $494,027 - $915,327
-12,872 Reduced 13.76%
80,670 $5.74 Million
Q3 2020

Nov 16, 2020

BUY
$27.2 - $42.19 $2.54 Million - $3.95 Million
93,542 New
93,542 $3.51 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.12B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.